Prognosis of Pulmonary Arterial Hypertension
- 13 July 2010
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 122 (2), 106-108
- https://doi.org/10.1161/circulationaha.110.963983
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- Immortal Time Bias in PharmacoepidemiologyAmerican Journal of Epidemiology, 2007
- Pulmonary Arterial Hypertension in FranceAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJournal of the American College of Cardiology, 2002
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996